Inhibikase TherapeuticsIKT 
$1.170.86%24h
0.86%24h
Global rank33628
Market cap$7.22M
Change 7d-1.68%
YTD Performance-12.03%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Inhibikase Therapeutics (IKT)
As of November 2024, Inhibikase Therapeutics has a market cap of $7.22M. This makes Inhibikase Therapeutics the world's 33628th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Inhibikase Therapeutics from 2020 to 2024
-
Value:-
Market cap history of Inhibikase Therapeutics from 2020 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $15.13M | 92.91% |
| 2023 | $7.84M | -57.67% |
| 2022 | $18.52M | -65.99% |
| 2021 | $54.46M | -78.70% |
| 2020 | $255.62M | - |
IKT Market Cap Today is $7.22M 0.86% - 21 Nov 2024
View largest stocks by market cap 
